← All companies

ATAI

AtaiBeckley Inc.

ATAI Nasdaq Pharmaceutical Preparations EDGAR ↗

$7.18

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$2.64B

Revenue (TTM)

$4.09M

Net income (TTM)

-$660M

EPS (TTM)

$-2.91

P/E ratio

—

Dividend yield

—

Free cash flow

-$104M

Cash

$43.1M

Total assets

$265M

Gross margin

—

52-week range

$3.27 – $7.22

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Regulation FD disclosure Jul 16, 2026 8-K Shareholder vote results Jun 8, 2026 8-K Regulation FD disclosure Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Entered a material agreement Mar 9, 2026 8-K Other events Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 6, 2026 8-K Regulation FD disclosure Feb 26, 2026 8-K Director or officer change; Regulation FD disclosure Feb 19, 2026 8-K Director or officer change; Regulation FD disclosure Jan 8, 2026

Other filings

PREM14A Jul 30, 2026 SCHEDULE 13G Jul 27, 2026 SCHEDULE 13D/A Jul 17, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 DEFA14A Jul 16, 2026 4 FORM 4 Jul 9, 2026 144 Jul 7, 2026 4 FORM 4 Jun 29, 2026 4 FORM 4 Jun 29, 2026 144 Jun 26, 2026 144 Jun 25, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Jun 8, 2026 4 FORM 4 Apr 22, 2026